Drs Cheryl Lee and Shekinah Elmore talk about how stereotactic body radiation therapy (SBRT) is being used in the treatment of oligometastatic bladder cancer — and how it's making a difference in patients' lives.

Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/987108). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

Resources

ESTRO ACROP Guidelines for External Beam Radiotherapy of Patients With Uncomplicated Bone Metastases https://www.estro.org/About/Newsroom/Newsletter/Read-it-before-your-patients/ESTRO-ACROP-guidelines-for-external-beam-radio-(1)

Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastatic (1-3 Metastases) Cancer (SABR-COMET-3) https://clinicaltrials.gov/ct2/show/NCT03862911

IMRT https://www.cancer.gov/publications/dictionaries/cancer-terms/def/imrt

Metastasis-directed Radiation Therapy With Consolidative Intent for Oligometastatic Urothelial Carcinoma: A Systematic Review and Meta-analysis https://pubmed.ncbi.nlm.nih.gov/35625979/

Trimodality Therapy for Bladder Cancer: Modern Management and Future Directions https://pubmed.ncbi.nlm.nih.gov/30855374/